3.0
Jan 1, 2025
Current employee, more than 3 years
London, England
Recommend
CEO approval
Business Outlook
Pros
Broad portfolio of products Experienced CEO leadership Uncapped commissions
Cons
- Acquisition of Bioclinica, changes in leadership and re-structuring created wide spread challenges - Future is very uncertain with sale of company very likely in near term - Lots of politics in middle management